Scientists at the German Centre for Cardiovascular Research (DZHK) have started a study to find out whether a monoclonal antibody restoring vascular integrity is safe and has positive effects on organ functions of patients with cardiogenic shock. The multicenter trial is sponsored by the University of Hamburg, financially supported by the biopharmaceutical company Adrenomed AG, and led by Dr. Mahir Karakas, DZHK partner site Hamburg/Kiel/Lübeck.
Cardiogenic shock is characterized by systemic hypoperfusion due to severe depression of the cardiac index and sustained systolic arterial hypotension. With a short-term mortality beyond 40 percent, it represents the major cause of death in acute myocardial infarction (AMI).
While rates of cardiogenic shock following AMI were stable at 8 percent during the 1990´ies, they are now climbing towards 12 percent during the last 10 years. Its socioeconomic impact is tremendous, considering 100,000 - 120,000 cases per year in the United States and Europe.
The now started randomized, placebo-controlled, double-blind, multicenter study ACCOST-HH assesses safety, tolerability and efficacy of a single dose of humanized monoclonal antibody Adrecizumab in up to 300 patients with early cardiogenic shock. Patients diagnosed with cardiogenic shock will receive Adrecizumab plus standard of care vs placebo plus standard of care.
The primary endpoint of this study is defined as number of days through day 30 without need for cardiovascular organ support, including mechanical support –a strong surrogate endpoint for mortality. Furthermore, tolerability and treatment-emergent adverse events over 90 days will be assessed. Two Phase-I studies already demonstrated safety of Adrecizumab.
Adrecizumab is a humanized monoclonal antibody, designed as first-in-class therapy to restore and maintain vascular integrity. The antibody specifically targets adrenomedullin, a key regulator of endothelial barrier function, blood pressure and vascular tone. Loss of vascular integrity plays a pivotal role in the development of vascular leakage and organ dysfunction leading to cardiogenic shock.
Adrecizumab prolongs the half-life of adrenomedullin and moreover, it is hypothesized that it shifts adrenomedullin from the interstitium to the circulation. Consequently, the level of functional adrenomedullin within the circulation is increased where it can exert its multiple beneficial effects.
This is important, since several animal studies have shown that adrenomedullin administration improves outcome of sepsis, shock and myocardial infarction, while it was recognized that therapeutic administration of adrenomedullin is not feasible due to pharmacokinetic limitations.
In preclinical studies, Adrecizumab reduced mortality from sepsis and positively impacted the vasoactive adrenomedullin system leading to stabilization of blood pressure, renal function and improved catecholamine responsiveness.
Beyond establishment of vascular integrity, adrenomedullin shows strong anti-inflammatory properties, is key to cardiomyocyte survival during and after myocardial ischemia, and has a marked anti-apoptotic effect on cardiomyocytes, as recently demonstrated in a molecular study conducted within the University Heart Center and published in the journal “Proceedings of the National Academy of Sciences of the United States of America (PNAS)“.
“Pathophysiologically, cardiogenic shock combines a deadly trias – myocardial cell death, inflammatory exacerbation, and loss of vascular integrity”, said Dr. Karakas, coordinating Principal Investigator of the ACCOST-HH study. “With Adrecizumab we might have the first causative therapy and hope to be able to reduce the high mortality rates".
Privatdozent Dr. Mahir Karakas, Klinik und Poliklinik für Allgemeine und Interventionelle Kardiologie, Universitäres Herzzentrum Hamburg GmbH, email@example.com
Christine Vollgraf | idw - Informationsdienst Wissenschaft
If Machines Could Smell ...
19.07.2019 | Fraunhofer-Institut für Produktionstechnik und Automatisierung IPA
Algae-killing viruses spur nutrient recycling in oceans
18.07.2019 | Rutgers University
Adjusting the thermal conductivity of materials is one of the challenges nanoscience is currently facing. Together with colleagues from the Netherlands and Spain, researchers from the University of Basel have shown that the atomic vibrations that determine heat generation in nanowires can be controlled through the arrangement of atoms alone. The scientists will publish the results shortly in the journal Nano Letters.
In the electronics and computer industry, components are becoming ever smaller and more powerful. However, there are problems with the heat generation. It is...
Scientists have visualised the electronic structure in a microelectronic device for the first time, opening up opportunities for finely-tuned high performance electronic devices.
Physicists from the University of Warwick and the University of Washington have developed a technique to measure the energy and momentum of electrons in...
Scientists at the University Würzburg and University Hospital of Würzburg found that megakaryocytes act as “bouncers” and thus modulate bone marrow niche properties and cell migration dynamics. The study was published in July in the Journal “Haematologica”.
Hematopoiesis is the process of forming blood cells, which occurs predominantly in the bone marrow. The bone marrow produces all types of blood cells: red...
For some phenomena in quantum many-body physics several competing theories exist. But which of them describes a quantum phenomenon best? A team of researchers from the Technical University of Munich (TUM) and Harvard University in the United States has now successfully deployed artificial neural networks for image analysis of quantum systems.
Is that a dog or a cat? Such a classification is a prime example of machine learning: artificial neural networks can be trained to analyze images by looking...
An international research group led by scientists from the University of Bayreuth has produced a previously unknown material: Rhenium nitride pernitride. Thanks to combining properties that were previously considered incompatible, it looks set to become highly attractive for technological applications. Indeed, it is a super-hard metallic conductor that can withstand extremely high pressures like a diamond. A process now developed in Bayreuth opens up the possibility of producing rhenium nitride pernitride and other technologically interesting materials in sufficiently large quantity for their properties characterisation. The new findings are presented in "Nature Communications".
The possibility of finding a compound that was metallically conductive, super-hard, and ultra-incompressible was long considered unlikely in science. It was...
24.06.2019 | Event News
29.04.2019 | Event News
17.04.2019 | Event News
19.07.2019 | Physics and Astronomy
19.07.2019 | Physics and Astronomy
19.07.2019 | Earth Sciences